Literature DB >> 23572336

Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis.

Mirko Manetti, Serena Guiducci, Eloisa Romano, Silvia Bellando-Randone, Gemma Lepri, Cosimo Bruni, Maria Letizia Conforti, Lidia Ibba-Manneschi, Marco Matucci-Cerinic.   

Abstract

Entities:  

Keywords:  Cytokines; Qualitative research; Systemic Sclerosis

Mesh：

Substances：

Year:  2013        PMID： 23572336     DOI： 10.1136/annrheumdis-2012-203183

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Acroosteolysis in systemic sclerosis: An insight into hypoxia-related pathogenesis.

Authors:  Simon Siao-Pin; Laura-Otilia Damian; Laura Mirela Muntean; Simona Rednic
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

2.  Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation.

Authors:  Claudio Corallo; Maurizio Cutolo; Nila Volpi; Daniela Franci; Margherita Aglianò; Antonio Montella; Chiara Chirico; Stefano Gonnelli; Ranuccio Nuti; Nicola Giordano
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-10-03       Impact factor: 5.346

Review 3.  Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.

Authors:  Colin Ligon; Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.592

4.  Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis.

Authors:  Jin Kyun Park; Andrea Fava; John Carrino; Filippo Del Grande; Antony Rosen; Francesco Boin
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 5.  Endothelial-to-mesenchymal transition in systemic sclerosis.

Authors:  P Cipriani; R Giacomelli; P Di Benedetto; P Ruscitti; O Berardicurti; M Vomero; L Navarini; V Dolo
Journal:  Clin Exp Immunol       Date:  2021-04-18       Impact factor: 5.732

6.  Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.

Authors:  Annalisa Borghini; Mirko Manetti; Francesca Nacci; Silvia Bellando-Randone; Serena Guiducci; Marco Matucci-Cerinic; Lidia Ibba-Manneschi; Elisabetta Weber
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

7.  Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis.

Authors:  Paola Cipriani; Paola Di Benedetto; Daria Capece; Francesca Zazzeroni; Vasiliki Liakouli; Piero Ruscitti; Ilenia Pantano; Onorina Berardicurti; Francesco Carubbi; Edoardo Alesse; Roberto Giacomelli
Journal:  Fibrogenesis Tissue Repair       Date:  2014-09-15

8.  Inhibition of angiogenesis by platelets in systemic sclerosis patients.

Authors:  Daniela Hirigoyen; Paula I Burgos; Veronica Mezzano; Josefina Duran; Magaly Barrientos; Claudia G Saez; Olga Panes; Diego Mezzano; Mirentxu Iruretagoyena
Journal:  Arthritis Res Ther       Date:  2015-11-19       Impact factor: 5.156

9.  Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.

Authors:  Paola Cipriani; Paola Di Benedetto; Piero Ruscitti; Antonio Francesco Campese; Vasiliki Liakouli; Francesco Carubbi; Ilenia Pantano; Onorina Berardicurt; Isabella Screpanti; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2014-09-24       Impact factor: 5.156

10.  The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

Authors:  Mirko Manetti; Serena Guiducci; Marco Matucci-Cerinic
Journal:  Arthritis Res Ther       Date:  2016-02-05       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.